Cargando…

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock

Detalles Bibliográficos
Autores principales:	Brunkhorst, FM, Wegscheider, K, Forycki, ZF, Brunkhorst, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301797/ http://dx.doi.org/10.1186/cc469

Ejemplares similares

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock – a systematic review and meta-analysis
por: Prkno, Anna, et al.
Publicado: (2013)

Antimicrobial treatment in patients with severe sepsis and septic shock: results from the German Prevalence Study
por: Brunkhorst, F, et al.
Publicado: (2006)

Prognostic value of the bone marrow in severe sepsis/septic shock
por: Milheiro, R, et al.
Publicado: (1999)

Procalcitonin serum concentrations do not differentiate severity of septic shock in postoperative patients
por: Weiss, M, et al.
Publicado: (2000)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Procalcitonin-guided therapy in severe sepsis and septic shock
por: Gu, Wan-Jie, et al.
Publicado: (2014)

Circulating complement proteins for differentiation of SIRS and sepsis
por: Sungurtekin, H, et al.
Publicado: (2003)

Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2000)

Epidemiology of severe sepsis and septic shock in Germany: results from the German 'Prevalence' study
por: Brunkhorst, FM, et al.
Publicado: (2005)

Representative survey of criteria used for the diagnosis of severe sepsis/septic shock among German ICU physicians: results from the German Prevalence Study
por: Brunkhorst, F, et al.
Publicado: (2006)

Cost-effectiveness of early goal-directed therapy in the treatment of severe sepsis and septic shock
por: Huang, DT, et al.
Publicado: (2003)

The impairment of small nerve fibers in severe sepsis and septic shock
por: Axer, Hubertus, et al.
Publicado: (2016)

Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock
por: Hohn, Andreas, et al.
Publicado: (2013)

Rate of microbiologically proven infections among patients with severe sepsis/septic shock: results from the German prevalence study
por: Brunkhorst, F, et al.
Publicado: (2006)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Acidosis and mortality in severe sepsis and septic shock evaluated by base excess variation
por: Palma, LC, et al.
Publicado: (2003)

How well does TOKS identify patients with severe sepsis or septic shock?
por: Tanderup, Anette, et al.
Publicado: (2013)

Impact of socioeconomic status on mortality and morbidity in patients with severe sepsis and septic shock
por: Schnegelsberg, Amal, et al.
Publicado: (2015)

Lipopolysaccharide binding protein: a poor parameter for the differentiation of SIRS and sepsis but useful as determinant of outcome in septic patients
por: Prucha, M, et al.
Publicado: (2002)

Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013)

Procalcitonin is a good marker for the diagnosis of infection and the severity of illness in patients with SIRS
por: Endo, S, et al.
Publicado: (1999)

Arterio- and veno-venosus hemofiltration in the treatment of sepsis and septic shock
por: Marjanek, Zs, et al.
Publicado: (2002)

Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
por: Anglès, O, et al.
Publicado: (2000)

Procalcitonin kinetics as a prognostic marker in severe sepsis/septic shock
por: Poddar, Banani, et al.
Publicado: (2015)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

C5a receptor expression on leukocytes from patients with severe sepsis or septic shock
por: Furebring, M, et al.
Publicado: (2001)

Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
por: Huang, Min-Yi, et al.
Publicado: (2016)

Usefulness of intrathoracic blood volume in the early phase of hemodynamic instability of patients with sepsis or septic shock
por: Sakka, SG, et al.
Publicado: (1999)

Mobilization of leukocytes in patients with severe sepsis and septic shock is associated with increased apoptosis, as detected by Annexin V binding
por: Weiss, M, et al.
Publicado: (2001)

Peaks in G-CSF serum concentrations are accompanied by an increase in phagocytotic activity in most patients with severe sepsis or septic shock
por: Fischer, G, et al.
Publicado: (2001)

SIRS in ICU: a different approach in sepsis assessment: clinical predictivity, severity scores, costs
por: Oggioni, R, et al.
Publicado: (1997)

Severe Sepsis and Septic Shock
por: Opal, Steven M.
Publicado: (2008)

C-reactive protein and procalcitonin during course of sepsis and septic shock
por: Schupp, Tobias, et al.
Publicado: (2023)

Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
por: Stiletto, RJ, et al.
Publicado: (1998)

Differential diagnosis of Th1/Th2-response by T-cell and monocyte function between sepsis and non-infectious SIRS via flowcytometry
por: Imamura, Y, et al.
Publicado: (2001)

Autoantibodies against oxidated low density lipoproteins (oLAb) and procalcitonin (PCT) as prognostic markers for patients suffering from sepsis and systemic inflammatory response syndrome (SIRS)
por: Reiger, J, et al.
Publicado: (1998)

Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock
por: Hohn, Andreas, et al.
Publicado: (2018)

Evaluation of procalcitonin as a diagnostic and prognostic marker in patients with sepsis, severe sepsis and septic shock associated with ventilator-associated pneumonia
por: Virtzili, S, et al.
Publicado: (2005)

Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock
por: Hu, Chenggong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5qudpa49rgt94qiuve54m1tec9